Johnson & Johnson Stock Surges 043% Amid Market Sell-Off Ranking 55th in Trading Volume

On March 26, 2025, Johnson & Johnson (JNJ) saw a trading volume of 11.68 billion, ranking 55th in the day's market activity. The stock price increased by 0.43%.

Jim Cramer, the host of Mad Money, highlighted Johnson & Johnson as a rare winner amidst the recent market sell-off. He emphasized the significance of the Federal Reserve in influencing market trends and acknowledged that any negative remarks could impact the market. Cramer's analysis underscored the resilience of Johnson & Johnson's stock performance during turbulent market conditions.

Additionally, a recent study revealed that a drug combination developed by Johnson & Johnson outperformed leading lung cancer treatments in terms of survival rates. This positive development further bolstered investor confidence in the company's pharmaceutical division, contributing to the stock's upward trajectory.